Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raoul Bergner

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Viruses|August 26, 2023
BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort StudyClaudius Speer, Maximilian Töllner, Louise Benning, et al.
The Lancet. Rheumatology|January 22, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trialNils Venhoff, Wolfgang A Schmidt, Raoul Bergner, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Clinical and Experimental Rheumatology|April 29, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patientsPia Wallmeier, Sabrina Arnold, Arlette Tais, et al.
Clinical and Experimental Rheumatology|April 12, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patientsSabrina Arnold, Pia Wallmeier, Arlette Tais, et al.
The Journal of Rheumatology|November 17, 2018
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International StudyMarco Sebastiani, Konstantinos Triantafyllias, Andreina Manfredi, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Viruses|August 26, 2023
BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort StudyClaudius Speer, Maximilian Töllner, Louise Benning, et al.
The Lancet. Rheumatology|January 22, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trialNils Venhoff, Wolfgang A Schmidt, Raoul Bergner, et al.
Infection|October 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patientsMy-Luong Vuong, Omar Elkayal, Ruth Van Daele, et al.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Clinical and Experimental Rheumatology|April 29, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patientsPia Wallmeier, Sabrina Arnold, Arlette Tais, et al.
Clinical and Experimental Rheumatology|April 12, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patientsSabrina Arnold, Pia Wallmeier, Arlette Tais, et al.
The Journal of Rheumatology|November 17, 2018
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International StudyMarco Sebastiani, Konstantinos Triantafyllias, Andreina Manfredi, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Pageof 6